Dr. Reddy's [DRREDDY] vs Lupin [LUPIN] Detailed Stock Comparison

Dr. Reddy's Laboratories Ltd.

NSE
Loading...

Lupin Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Reddy's Laboratories Ltd. wins in 8 metrics, Lupin Ltd. wins in 12 metrics, with 0 ties. Lupin Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dr. Reddy's Laboratories Ltd. Lupin Ltd. Better
P/E Ratio (TTM) 19.40 22.74 Dr. Reddy's Laboratories Ltd.
Price-to-Book Ratio 2.94 5.37 Dr. Reddy's Laboratories Ltd.
Debt-to-Equity Ratio 18.03 31.51 Dr. Reddy's Laboratories Ltd.
PEG Ratio -1.35 0.60 Lupin Ltd.
EV/EBITDA 12.80 15.38 Dr. Reddy's Laboratories Ltd.
Profit Margin (TTM) 16.36% 17.76% Lupin Ltd.
Operating Margin (TTM) 16.42% 26.46% Lupin Ltd.
EBITDA Margin (TTM) 16.42% 26.46% Lupin Ltd.
Return on Equity 16.10% 18.98% Lupin Ltd.
Return on Assets (TTM) 7.96% 11.24% Lupin Ltd.
Free Cash Flow (TTM) $12.03B $13.18B Lupin Ltd.
Dividend Yield 11.59% 0.62% Dr. Reddy's Laboratories Ltd.
1-Year Return 4.18% 15.83% Lupin Ltd.
Price-to-Sales Ratio (TTM) 3.17 4.03 Dr. Reddy's Laboratories Ltd.
Enterprise Value $1,085.11B $1,054.33B Dr. Reddy's Laboratories Ltd.
EV/Revenue Ratio 3.14 4.03 Dr. Reddy's Laboratories Ltd.
Gross Profit Margin (TTM) 53.63% 73.55% Lupin Ltd.
Revenue per Share (TTM) $415 $573 Lupin Ltd.
Earnings per Share (Diluted) $67.88 $101.47 Lupin Ltd.
Beta (Stock Volatility) 0.30 0.28 Lupin Ltd.

Dr. Reddy's Laboratories Ltd. vs Lupin Ltd. Stock Performance Analysis

Loading Price Chart...

DRREDDY
LUPIN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Reddy's Laboratories Ltd.-0.84%-4.06%-1.03%-1.58%-0.09%1.64%
Lupin Ltd.0.51%-0.71%-4.21%-2.65%8.02%6.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Reddy's Laboratories Ltd.4.18%41.36%24.02%106.24%313.72%874.29%
Lupin Ltd.15.83%177.58%84.14%56.38%403.88%2,224.89%

Performance & Financial Health Analysis: Dr. Reddy's Laboratories Ltd. vs Lupin Ltd.

MetricDRREDDYLUPIN
Market Information
Market Cap i₹1.10T₹1.07T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,912,1621,119,327
90 Day Avg. Volume i2,668,2291,057,063
Last Close₹1,263.30₹2,261.20
52 Week Range₹1,148.40 - ₹1,379.70₹1,836.80 - ₹2,494.00
% from 52W High-8.44%-9.33%
All-Time High₹1,421.49 (Aug 19, 2024)₹2,459.00 (May 06, 2026)
% from All-Time High-11.13%-8.04%
Growth Metrics
Quarterly Revenue Growth0.04%0.24%
Quarterly Earnings Growth-0.14%0.38%
Financial Health
Profit Margin (TTM) i0.16%0.18%
Operating Margin (TTM) i0.16%0.26%
Return on Equity (TTM) i0.16%0.19%
Debt to Equity (MRQ) i18.0331.51
Cash & Liquidity
Book Value per Share (MRQ)₹447.25₹429.87
Cash per Share (MRQ)₹99.20₹137.55
Operating Cash Flow (TTM) i₹63.11B₹28.04B
Levered Free Cash Flow (TTM) i₹13.47B₹32.82B
Dividends
Last 12-Month Dividend Yield i11.59%0.62%
Last 12-Month Dividend i₹146.30₹12.00

Valuation & Enterprise Metrics Analysis: Dr. Reddy's Laboratories Ltd. vs Lupin Ltd.

MetricDRREDDY (Apr 26, 2026)LUPIN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.4022.74
Forward P/E i24.1223.46
PEG Ratio i-1.350.60
Price to Sales (TTM) i3.174.03
Price to Book (MRQ) i2.945.37
Market Capitalization
Market Capitalization i₹1.10T₹1.07T
Enterprise Value i₹1.09T₹1.05T
Enterprise Value Metrics
Enterprise to Revenue i3.144.03
Enterprise to EBITDA i12.8015.38
Risk & Other Metrics
Beta i0.300.28
Book Value per Share (MRQ) i₹447.25₹429.87

Financial Statements Comparison: Dr. Reddy's Laboratories Ltd. vs Lupin Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDRREDDY (2025)LUPIN (2025)
Revenue/Sales i325.54B221.92B
Cost of Goods Sold i135.11B74.56B
COGS % of Revenue i41.5%33.6%
Gross Profit i190.43B147.36B
Gross Margin i58.5%66.4%
Research & Development i27.38BN/A
Operating Income (EBIT) i72.01B43.45B
Operating Margin i22.1%19.6%
EBITDA i91.97B56.45B
EBITDA Margin i28.3%25.4%
Pre-Tax Income i76.78B40.15B
Pre-Tax Income % of Revenue i23.6%18.1%
Income Tax i19.54B7.09B
Income Tax % of Revenue i6.0%3.2%
Net Income (Profit) i57.25B33.06B
Profit Margin i17.6%14.9%

Balance Sheet & Liquidity Metrics

MetricDRREDDY (2025)LUPIN (2025)
Cash & Equivalents i14.65B19.31B
Total Current Assets i250.11B167.99B
Total Current Assets % of Revenue i76.8%75.7%
Total Current Liabilities i130.39B89.61B
Total Current Liabilities % of Revenue i40.1%40.4%
Long-Term Debt i7.86B20.31B
Long-Term Debt % of Revenue i2.4%9.1%
Total Shareholders Equity i337.17B172.94B
Retained Earnings i315.79B140.71B
Retained Earnings % of Revenue i97.0%63.4%
Property, Plant & Equipment i084.20M

Cash Flow Statement Comparison

MetricDRREDDY (2025)LUPIN (2025)
Operating Cash Flow i64.09B28.04B
Operating Cash Flow % of Revenue i19.7%12.6%
Capital Expenditures i-26.99B-16.53B
Free Cash Flow i12.03B13.18B
FCF Margin i3.7%5.9%
Debt Repayment i-1.29B0
Common Stock Repurchase i-1.39BN/A

Short Interest & Institutional Ownership Analysis

MetricDRREDDYLUPIN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i832.57M457.18M
Float Shares i599.15M241.86M
% Held by Insiders i29.45%47.03%
% Held by Institutions i51.84%34.14%
% Held by Public i18.71%18.83%

Dividend Analysis & Yield Comparison: Dr. Reddy's Laboratories Ltd. vs Lupin Ltd.

MetricDRREDDYLUPIN
Last 12-Month Dividend i₹146.30₹12.00
Last 12-Month Dividend Yield i11.59%0.62%
3-Year Avg Annual Dividend i₹49.30₹8.00
3-Year Avg Dividend Yield i3.74%0.50%
3-Year Total Dividends i₹147.90₹24.00
Ex-Dividend DateJul 10, 2025Jul 25, 2025